Medicine

Prof. Pat Pataranutaporn speaks with The Guardian reporter Andrew Gregory about the lack of safety warnings and disclaimers in AI overviews, specifically in AI-generated health materials. “The absence of disclaimers when users are initially served medical information creates several critical dangers,” says Pataranutaporn. “Disclaimers serve as a crucial intervention point. They disrupt this automatic trust and prompt users to engage more critically with the information they receive.”

A new study by researchers at MIT and elsewhere has found a correlation between addiction and eye care, reports Hadley Barndollar for MassLive. “The study found nearly half of the patients with opioid use disorder being treated for the eye infection were eligible to initiate medication-assisted treatment,” explains Barndollar. “But medications were only initiated when an addiction consult occurred, highlighting how much more eye doctors responding to emergency rooms can offer patients beyond vision care.” 

Senior Research Scientist Leo Anthony Celi speaks with New York Times reporter Gina Kolata about the use of AI in health care. “The real concern isn’t AI itself,” says Celi. “It’s the AI is being deployed to optimize a profoundly broken system rather than to reimagine it.” 

Researchers at MIT have developed a wearable breast cancer ultrasound device that could be used to detect breast cancer earlier, reports Amerigo Allegretto for AuntMinnie.com. “The device can image as deep as 15 cm into breast tissue and can image the entire breast from two or three locations,” explains Allegretto. “The team described the technology as an end-to-end system ultrasound architecture consisting of a novel sparse array geometry and a codesigned data acquisition system.” 

Prof. Marzyeh Ghassemi and Monica Agrawal PhD '23 speak with Boston Globe reporter Hiawatha Bray about the risks on relying solely on AI for medical information. “What I’m really, really worried about is economically disadvantaged communities,” says Ghassemi. “You might not have access to a health care professional who you can quickly call and say, ‘Hey… Should I listen to this?’”  

Prof. Giovanni Traverso and his colleagues developed a new technique that could one day be used to help protect cancer patients from the side effects of radiation therapy, reports Elie Dolgin for Science. The researchers found that providing brief pulses of a protein called “damage suppressor,” or Dsup could “shield injected tissues from radiation. They also found no evidence of acute toxicity with repeat doses, which bodes well for short-term use in clinical settings—for example, to protect nearby tissues during radiation treatment for a cancer,” Dolgin explains. 

MIT researchers have developed a new smart pill that could be used to help doctors track treatment more accurately, and ensure patients stay on their medication schedule, reports Kurt Knutsson for Fox News. “If you or a loved one relies on critical medication, this kind of technology could add an extra layer of safety,” Knuttson explains. “It may reduce guesswork for doctors and ease pressure on patients who manage complex treatment plans.” 

Forbes reporter Craig Smith spotlights Prof. Regina Barzilay for her work using her personal health experience to develop transformative medical technology. In response to her breast cancer diagnosis, Barzilay “developed a deep learning model that analyzes mammography images to predict breast cancer risk up to five years in advance,” writes Smith. 

In an effort to help medical professionals ensure patients are taking medications as prescribed, researchers at MIT have developed a “drug capsule containing an RFID tag that uses radiofrequency (RF) signals to communicate that it has been swallowed, and then bioresorbs into the body,” reports Tami Freeman for Physics World. “Medication non-adherence remains a major cause of preventable morbidity and cost, but existing ingestible tracking systems rely on non-degradable electronics,” explains Prof. Giovanni Traverso. Our motivation was to create a passive, battery-free adherence sensor that confirms ingestion while fully biodegrading, avoiding long-term safety and environmental concerns associated with persistent electronic devices.”  

Prof. Giovanni Traverso speaks with Claudia Hammond of BBC Health Check about a new pill he and his colleagues have developed that can send an alert when it’s been swallowed, which could help ensure patients are taking their medications as prescribed. “Researchers have estimated that in the US alone, people not taking their medication contributes to as many as 125,000 preventable deaths each year and costs more than $100 billion,” says Hammond. 

Researchers at MIT have developed an ingestible “smart pill” that uses radio frequency to communicate from the stomach when patients have taken their medications. “It may sound simple, but the stakes are high,” reports McKenzie Beard for the New York Post. “Studies show that half of all Americans with chronic conditions don’t take their long-term medications as prescribed.” 

Researchers at MIT have developed an ingestible pill that “contains a biodegradable radiofrequency antenna” which can be used to monitor patients’ medication intake, reports Nancy Lapid for Reuters. “After [the antenna] sends out the signal that the pill has been consumed, most components break down in the stomach while a tiny radiofrequency chip passes out of the body through the digestive tract,” explains Lapid. 

Prof. Giovanni Traverso and his colleagues have developed a pill that can report when it has been swallowed, which could be used to ensure patients are taking their medicine correctly. “According to the World Health Organization, nearly 50% of patients in need of long-term treatment do not take their medication as prescribed,” reports Inside Precision Medicine. “This new reporting system could be beneficial for a wide range of patient populations.” 

Researchers at MIT have developed an ingestible pill that can communicate from the stomach and could help monitor patients' medication use, reports Prabhat Ranjan Mishra for Interesting Engineering.  “After it sends out the signal that the pill has been consumed, most components break down in the stomach while a tiny RF chip passes out of the body through the digestive tract," writes Mishra. 

Prof. Lonnie Petersen speaks with Benjamin Rachlin, executive editor of MIT Horizon, about the future of space medicine in an article for The Boston Globe. “The next generation of flight surgeons might work from orbit. They might accompany a crew on a long-term mission, like a medic with a platoon,” writes Rachlin. “There is no standard yet for medical care in space. Doctors are inventing it.” Petersen notes that: “Space is like New York. If you can make it there, you can make it anywhere.”